Welcome to our dedicated page for Marpai news (Ticker: MRAI), a resource for investors and traders seeking the latest updates and insights on Marpai stock.
Marpai, Inc. reports recurring developments in healthcare technology, third-party administration and pharmacy benefit management services for employers that directly fund employee health benefits. The company operates subsidiaries that provide TPA, PBM and value-oriented health plan services, including the MarpaiRx pharmacy benefit platform and the Marpai Saves initiative.
News about MRAI commonly covers MarpaiRx client wins, marketing collaborations, network access arrangements with providers such as Aetna and Cigna, financial results, operating efficiency initiatives and leadership changes tied to its health benefits administration business.
Marpai, Inc. (Nasdaq: MRAI), a technology firm innovating in third-party administration within the healthcare sector, has announced the hiring of two marketing directors, Christina DiBona as Marketing Director for Member and Client Engagement, and Marcella Withers as Marketing Director for Brokers, Employers, and Partners. DiBona brings 20 years of marketing expertise, while Withers has over 16 years in brand strategy. CEO Edmundo Gonzalez highlighted the importance of these roles in enhancing member engagement and driving business growth amidst their deployment of deep learning technologies.
Marpai, Inc. (Nasdaq: MRAI) launched its new Gaps in Care service aimed at promoting preventive health among members by sending personalized reminders for annual exams and screenings. This service expands Marpai's AI-driven offerings designed to reduce chronic illnesses and health costs in the self-funded market, a sector representing over $1 trillion in health claims. Marpai serves over 50,000 members and collaborates with major networks like Aetna and Cigna, leveraging technology to improve health outcomes and lower expenses.
Marpai, Inc. (NASDAQ: MRAI) will be featured on The RedChip Money Report® on Bloomberg TV on Nov. 6 at 7 p.m. ET. The program focuses on small-cap investing and includes interviews with public company executives. Marpai utilizes deep learning technology to enhance healthcare third party administration, serving over 60 self-funded organizations and 40,000 members across the U.S. The interview aims to showcase the company’s innovations in reducing costs and improving health outcomes.
Marpai, Inc. (NASDAQ: MRAI) has successfully closed its initial public offering, selling 7,187,500 shares of common stock at $4.00 each, which resulted in gross proceeds of $28.75 million, excluding underwriting discounts and offering expenses. The offering included 937,500 shares sold through the underwriters' over-allotment option. ThinkEquity served as the sole book-running manager for this offering. The company utilizes deep learning technology to improve healthcare management for self-funded markets, serving over 60 self-funded companies and 40,000 members nationwide.
Marpai, Inc. (Nasdaq: MRAI) has priced its initial public offering (IPO) at $4.00 per share, raising gross proceeds of $25 million through the sale of 6,250,000 shares. An additional 937,500 shares may be purchased by underwriters to cover over-allotments. The shares are set to trade on the Nasdaq Capital Market starting October 27, 2021, with the offering closing on October 29, 2021. Marpai utilizes deep learning technology to transform third-party administration in the healthcare self-funded market, serving over 40,000 members across the U.S.